176 related articles for article (PubMed ID: 38216149)
1. Liposomal delivery of self-peptide and calcitriol as tolerogenic immunotherapy in rheumatoid arthritis: an exploration using sensory science.
Hee JY; Cai B; Thomas R
Immunol Cell Biol; 2024; 102(5):353-357. PubMed ID: 38216149
[TBL] [Abstract][Full Text] [Related]
2. PD-L1- and calcitriol-dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease.
Galea R; Nel HJ; Talekar M; Liu X; Ooi JD; Huynh M; Hadjigol S; Robson KJ; Ting YT; Cole S; Cochlin K; Hitchcock S; Zeng B; Yekollu S; Boks M; Goh N; Roberts H; Rossjohn J; Reid HH; Boyd BJ; Malaviya R; Shealy DJ; Baker DG; Madakamutil L; Kitching AR; O'Sullivan BJ; Thomas R
JCI Insight; 2019 Sep; 4(18):. PubMed ID: 31487265
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells, T cells and their interaction in rheumatoid arthritis.
Wehr P; Purvis H; Law SC; Thomas R
Clin Exp Immunol; 2019 Apr; 196(1):12-27. PubMed ID: 30589082
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T Cells Induced by Single-Peptide Liposome Immunotherapy Suppress Islet-Specific T Cell Responses to Multiple Antigens and Protect from Autoimmune Diabetes.
Bergot AS; Buckle I; Cikaluru S; Naranjo JL; Wright CM; Zheng G; Talekar M; Hamilton-Williams EE; Thomas R
J Immunol; 2020 Apr; 204(7):1787-1797. PubMed ID: 32111734
[TBL] [Abstract][Full Text] [Related]
5. Immune tolerance induction with multiepitope peptide derived from citrullinated autoantigens attenuates arthritis manifestations in adjuvant arthritis rats.
Gertel S; Serre G; Shoenfeld Y; Amital H
J Immunol; 2015 Jun; 194(12):5674-80. PubMed ID: 25964493
[TBL] [Abstract][Full Text] [Related]
6. Liposome-based immunotherapy against autoimmune diseases: therapeutic effect on multiple sclerosis.
Pujol-Autonell I; Mansilla MJ; Rodriguez-Fernandez S; Cano-Sarabia M; Navarro-Barriuso J; Ampudia RM; Rius A; Garcia-Jimeno S; Perna-Barrull D; Martinez-Caceres E; Maspoch D; Vives-Pi M
Nanomedicine (Lond); 2017 Jun; 12(11):1231-1242. PubMed ID: 28593827
[TBL] [Abstract][Full Text] [Related]
7. Autoantigen-Dexamethasone Conjugate-Loaded Liposomes Halt Arthritis Development in Mice.
Benne N; Ter Braake D; Porenta D; Lau CYJ; Mastrobattista E; Broere F
Adv Healthc Mater; 2024 May; 13(12):e2304238. PubMed ID: 38295848
[TBL] [Abstract][Full Text] [Related]
8. Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide/calcitriol liposomes in ACPA+ rheumatoid arthritis.
Sonigra A; Nel HJ; Wehr P; Ramnoruth N; Patel S; van Schie KA; Bladen MW; Mehdi AM; Tesiram J; Talekar M; Rossjohn J; Reid HH; Stuurman FE; Roberts H; Vecchio P; Gourley I; Rigby M; Becart S; Toes RE; Scherer HU; Lê Cao KA; Campbell K; Thomas R
JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36278483
[TBL] [Abstract][Full Text] [Related]
9. Antigen-specific therapy of rheumatoid arthritis.
Ichim TE; Zheng X; Suzuki M; Kubo N; Zhang X; Min LR; Beduhn ME; Riordan NH; Inman RD; Min WP
Expert Opin Biol Ther; 2008 Feb; 8(2):191-9. PubMed ID: 18194075
[TBL] [Abstract][Full Text] [Related]
10. Making science accessible for blind and low-vision people, and those with diverse needs.
Borger JG
Immunol Cell Biol; 2024; 102(5):308-314. PubMed ID: 38724046
[TBL] [Abstract][Full Text] [Related]
11. Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis.
Satpute SR; Durai M; Moudgil KD
Semin Arthritis Rheum; 2008 Dec; 38(3):195-207. PubMed ID: 18177689
[TBL] [Abstract][Full Text] [Related]
12. Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial.
Koffeman EC; Genovese M; Amox D; Keogh E; Santana E; Matteson EL; Kavanaugh A; Molitor JA; Schiff MH; Posever JO; Bathon JM; Kivitz AJ; Samodal R; Belardi F; Dennehey C; van den Broek T; van Wijk F; Zhang X; Zieseniss P; Le T; Prakken BA; Cutter GC; Albani S
Arthritis Rheum; 2009 Nov; 60(11):3207-16. PubMed ID: 19877047
[TBL] [Abstract][Full Text] [Related]
13. Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?
Hilkens CM; Isaacs JD
Clin Exp Immunol; 2013 May; 172(2):148-57. PubMed ID: 23574312
[TBL] [Abstract][Full Text] [Related]
14. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens.
Almenara-Fuentes L; Rodriguez-Fernandez S; Rosell-Mases E; Kachler K; You A; Salvado M; Andreev D; Steffen U; Bang H; Bozec A; Schett G; Le Panse R; Verdaguer J; Dalmases M; Rodriguez-Vidal S; Barneda-Zahonero B; Vives-Pi M
Nanomedicine; 2023 Feb; 48():102635. PubMed ID: 36481472
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry.
Rodriguez-Fernandez S; Pujol-Autonell I; Brianso F; Perna-Barrull D; Cano-Sarabia M; Garcia-Jimeno S; Villalba A; Sanchez A; Aguilera E; Vazquez F; Verdaguer J; Maspoch D; Vives-Pi M
Front Immunol; 2018; 9():253. PubMed ID: 29491866
[TBL] [Abstract][Full Text] [Related]
16. Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis.
Schinnerling K; Soto L; García-González P; Catalán D; Aguillón JC
Autoimmun Rev; 2015 Jun; 14(6):517-27. PubMed ID: 25633325
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis.
Thomas R
Arthritis Res Ther; 2013 Feb; 15(1):204. PubMed ID: 23374912
[TBL] [Abstract][Full Text] [Related]
18. Heat Shock Proteins Can Be Surrogate Autoantigens for Induction of Antigen Specific Therapeutic Tolerance in Rheumatoid Arthritis.
van Eden W; Jansen MAA; Ludwig IS; Leufkens P; van der Goes MC; van Laar JM; Broere F
Front Immunol; 2019; 10():279. PubMed ID: 30873163
[TBL] [Abstract][Full Text] [Related]
19. Cell-based Tolerogenic Therapy, Experience from Animal Models of Multiple Sclerosis, Type 1 Diabetes and Rheumatoid Arthritis.
Stojanovic I; Dimitrijevic M; Vives-Pi M; Mansilla MJ; Pujol-Autonell I; Rodríguez-Fernandez S; Palova-Jelínkova L; Funda DP; Gruden-Movsesijan A; Sofronic-Milosavljevic L; Hilkens CMU; Martinez-Caceres E; Miljkovic D
Curr Pharm Des; 2017; 23(18):2623-2643. PubMed ID: 28201972
[TBL] [Abstract][Full Text] [Related]
20. Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes.
Pujol-Autonell I; Serracant-Prat A; Cano-Sarabia M; Ampudia RM; Rodriguez-Fernandez S; Sanchez A; Izquierdo C; Stratmann T; Puig-Domingo M; Maspoch D; Verdaguer J; Vives-Pi M
PLoS One; 2015; 10(6):e0127057. PubMed ID: 26039878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
